Related Experiment Video
Updated: Jul 2, 2026
12:22
The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
33.6K
Biomarqueurs émergents dans les cancers du rein à cellules claires
1Service oncologie médicale, ICANS, Strasbourg.
Bulletin Du Cancer
|June 30, 2024
Abstract:
Emerging biomarkers in clear cell kidney cancer.
Insights
New biomarkers are emerging for clear cell kidney cancer. These discoveries offer hope for improved diagnostics and targeted treatments for this specific cancer type.
Area of Science:
- Oncology
- Biomarker Discovery
- Genitourinary Cancers
Background:
- Clear cell kidney cancer (ccRCC) is the most common subtype of kidney cancer.
- Current diagnostic and prognostic tools for ccRCC have limitations.
- There is a critical need for novel biomarkers to improve patient outcomes.
Purpose of the Study:
- To review and summarize emerging biomarkers for clear cell kidney cancer.
- To highlight the potential clinical applications of these novel biomarkers.
- To discuss the future directions in ccRCC biomarker research.
Main Methods:
- Comprehensive literature search of peer-reviewed articles.
- Analysis of studies reporting on novel biomarkers in ccRCC.
- Synthesis of findings related to diagnostic, prognostic, and predictive biomarkers.
Main Results:
- Several novel biomarkers, including genetic mutations, protein expression levels, and circulating tumor DNA (ctDNA), show promise in ccRCC.
- These biomarkers demonstrate potential for early detection, risk stratification, and prediction of treatment response.
- Validation studies are ongoing for many promising candidates.
Conclusions:
- Emerging biomarkers offer significant potential to revolutionize the management of clear cell kidney cancer.
- Further research and clinical validation are essential to integrate these biomarkers into routine practice.
- Personalized medicine approaches in ccRCC will be advanced by these biomarker discoveries.
More Related Videos
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...